Immediate Impact
70 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Clinical applications of stem cell-derived exosomes
2024 Standout
Works of Xiaowei Shen being referenced
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway
2021
Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaowei Shen | 155 | 92 | 55 | 57 | 34 | 323 | |
| Wang Li | 201 | 115 | 44 | 55 | 30 | 307 | |
| Xinan Wang | 181 | 73 | 51 | 42 | 35 | 362 | |
| Xiangyu Zheng | 163 | 64 | 65 | 56 | 35 | 350 | |
| Ling Shi | 215 | 83 | 50 | 44 | 24 | 349 | |
| Yu Zeng | 191 | 76 | 64 | 75 | 42 | 307 | |
| Dan Liu | 198 | 96 | 47 | 35 | 35 | 326 | |
| Yan Zhao | 157 | 90 | 95 | 45 | 27 | 312 | |
| Xiaoyu Wang | 171 | 82 | 68 | 46 | 25 | 299 | |
| Zsuzsanna Mihály | 190 | 98 | 80 | 95 | 26 | 342 | |
| Jianqing Lin | 191 | 109 | 72 | 51 | 33 | 331 |
All Works
Login with ORCID to disown or claim papers
Loading papers...